Ligne de temps

Clarisse Ganier
Post-doctorant(e)
01 sept. 2024
publication

Unlocking Skin’s Symphony: Single-Cell and Spatial Transcriptomics Reveal the Harmonious Interplay among Diverse Cell Populations.

Lire plus
01 sept. 2024
publication

Neutral evolution of snoRNA Host Gene long non-coding RNA affects cell fate control.

Lire plus
19 juin 2024
publication

Young ESDR: Engaging and Nurturing the Next-Generation Skin Research Community.

Lire plus
01 févr. 2024
publication

Recommendations for accelerating open preprint peer review to improve the culture of science.

Lire plus
01 févr. 2024
publication

Genome-wide meta-analysis implicates variation affecting mast cell biology in urticaria.

Lire plus
30 janv. 2024
publication

Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade.

Lire plus
09 janv. 2024
publication

Multiscale spatial mapping of cell populations across anatomical sites in healthy human skin and basal cell carcinoma.

Lire plus
14 nov. 2023
publication

Single-cell RNA sequencing of human epidermis identifies Lunatic fringe as a novel regulator of the stem cell compartment.

Lire plus
01 oct. 2023
publication

Myc-dependent dedifferentiation of Gata6+ epidermal cells resembles reversal of terminal differentiation.

Lire plus
06 juin 2022
publication

Fibroblast Heterogeneity in Healthy and Wounded Skin.

Lire plus
01 avr. 2022
publication

Angiotensin-Converting Enzyme 2 Expression Is Detectable in Keratinocytes, Cutaneous Appendages, and Blood Vessels by Multiplex RNA In Situ Hybridization.

Lire plus
01 mars 2022
publication

Gradient boosting approaches can outperform logistic regression for risk prediction in cutaneous allergy.

Lire plus
01 avr. 2021
publication

Clinically Relevant Vulnerabilities of Deep Machine Learning Systems for Skin Cancer Diagnosis.

Lire plus
01 nov. 2018
publication

Intradermal Injection of Bone Marrow Mesenchymal Stromal Cells Corrects Recessive Dystrophic Epidermolysis Bullosa in a Xenograft Model.

Lire plus
07 sept. 2018
publication

Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair.

Lire plus
01 juil. 2016
publication

Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.

Lire plus